切换至 "中华医学电子期刊资源库"
高级检索
中华普通外科学文献(电子版)

中华普通外科学文献(电子版) ›› 2013, Vol. 07 ›› Issue (05) : 347 -349. doi: 10.3877/cma.j.issn.1674-0793.2013.05.004

所属专题： 文献；

论著

2-脱氧-D-葡萄糖联合氟尿嘧啶对胃癌细胞MGC-803凋亡影响的实验研究
章斐然1, 李威1,†(), 郑仰1, 陈君填1   
  1. 1. 515041　汕头大学医学院第一附属医院
  • 收稿日期:2013-06-23 出版日期:2013-10-01
  • 通信作者: 李威
  • 基金资助:
    广东省科技计划项目(2011B031800189)

Effects of 2-deoxy-D-glucose and 5-Fu on proliferation and apoptosis of human gastric cancer MGC-803 cells

Fei-ran ZHANG1, Wei LI1,†(), Yang ZHENG1, Jun-tian CHEN1   

  1. 1. Department of General Surgery, First Affiliated Hospital, ShanTou University Medical College, Shantou 515041, China
  • Received:2013-06-23 Published:2013-10-01
  • Corresponding author: Wei LI
  • About author:
    Corresponding author: LI Wei, Email:
全文 ( ) 下载PDF ( ) 导出引用
引用本文：

章斐然, 李威, 郑仰, 陈君填. 2-脱氧-D-葡萄糖联合氟尿嘧啶对胃癌细胞MGC-803凋亡影响的实验研究[J]. 中华普通外科学文献(电子版), 2013, 07(05): 347-349.

Fei-ran ZHANG, Wei LI, Yang ZHENG, Jun-tian CHEN. Effects of 2-deoxy-D-glucose and 5-Fu on proliferation and apoptosis of human gastric cancer MGC-803 cells[J]. Chinese Archives of General Surgery(Electronic Edition), 2013, 07(05): 347-349.

目的

探讨糖酵解抑制剂2-脱氧-D-葡萄糖（2-DG）与氟尿嘧啶（5-Fu）单独及联合应用对人胃癌细胞MGC-803增殖及凋亡的影响。

方法

实验设立2-DG组、5-Fu组、联合组（2-DG +5-Fu）及空白对照组，将2-DG（10 mmol/L）及5-Fu（5.0 μg/L）单药及联合用药作用于人胃癌细胞MGC-803，MTT法检测各组MGC-803细胞的增殖抑制率，流式细胞仪检测各组细胞凋亡情况。

结果

2-DG和5-Fu均可使胃癌细胞增殖受到抑制并可诱导细胞凋亡，两药合用后其作用明显增强。

结论

2-DG能有效抑制人胃癌细胞MGC-803细胞生长增殖，并诱导其凋亡；2-DG与5-Fu联合应用抗肿瘤作用明显增强。

关键词: 2-脱氧-D-葡萄糖, 胃癌, 细胞凋亡
Objective

To investigate the effects of 2-deoxy-D-glucose ( 2-DG) or 5-Fu alone and the combination of both on the proliferation and apoptosis of human gastric cancer MGC-803 cells.

Methods

Human gastric cancer MGC-803 cells were treated with 2-DG or 5-Fu alone, or both. The inhibitory effect on the proliferation of MGC-803 cells was detected by MTT method. Apoptotic rate was assayed by flow cytometry.

Results

2-DG or 5-Fu inhibited the growth of MGC-803 cells obviously and induced the apoptosis. When 2-DG and 5-Fu were combined, the inhibitory effect and apoptotic rate were improved (P<0.05).

Conclusions

2-DG inhibits the growth of human gastric cancer MGC-803 cells. The combination of 2-DG and 5-Fu improves the ability of 5-Fu to attack the tumor cells.

Key words: 2-deoxy-D-glucose, Gastric cancer, Apoptosis
1
耿翔，周奇，刘超, 等. 2-脱氧-D-葡萄糖与奥沙利铂对人肝癌SMMC-7721细胞增殖及凋亡的影响. 中国病理生理杂志, 2011, 27(11): 2101-2105.
2
韩保卫，刘光辉，董帅军, 等. 糖酵解抑制剂对低氧胰腺癌细胞增殖和凋亡的影响. 中国普通外科杂志, 2009, 18(3): 243-246.
3
程秀，刘浩，方琳, 等. 2-DG增强乳腺癌细胞对阿霉素化疗敏感性的作用. 中国药理学通报, 2010, 26(10): 1371-1376.
4
Sottnik JL, Lori JC, Rose BJ, et al. Glycolysis inhibition by 2-deoxy-D-glucose reverts the metastatic phenotype in vitro and in vivo. Clin Exp Metastasis, 2011, 28(8): 865-875.
5
Yamaguchi R, Perkins G. Finding a Panacea among combination cancer therapies. Cancer Res, 2012, 72(1): 18-23.
6
Estañ MC, Calviño E, de Blas E, et al. 2-Deoxy-D-glucose cooperates with arsenic trioxide to induce apoptosis in leukemia cells: involvement of IGF-1R-regulated Akt/mTOR, MEK/ERK and LKB-1/AMPK signaling pathways. Biochem Pharmacol, 2012, 84(12): 1604-1616.
7
Gupta S, Farooque A, Adhikari JS, et al. Enhancement of radiation and chemotherapeutic drug responses by 2-deoxy-D -glucose in animal tumors. J Cancer Res Ther, 2009, 5 Suppl 1: S16-20.
8
Hadzic T, Aykin-Burns N, Zhu Y, et al. Paclitaxel combined with inhibitors of glucose and hydroperoxide metabolism enhances breast cancer cell killing via H2O2-mediated oxidative stress. Free Radic Biol Med, 2010, 48(8): 1024-1033.
9
Bhardwaj R, Sharma PK, Jadon SP, et al. A combination of 2-deoxy-D-glucose and 6-aminonicotinamide induces cell cycle arrest and apoptosis selectively in irradiated human malignant cells. Tumour Biol, 2012, 33(4): 1021-1030.
10
Aghaee F, Pirayesh Islamian J, Baradaran B. Enhanced radiosensitivity and chemosensitivity of breast cancer cells by 2-deoxy-d-glucose in combination therapy. J Breast Cancer, 2012, 15(2): 141-147.
11
Heyfets A, Flescher E. Cooperative cytotoxicity of methyl jasmonate with anti-cancer drugs and 2-deoxy-D-glucose. Cancer Lett, 2007, 250(2): 300-310.
12
Merchan JR, Kovács K, Railsback JW, et al. Antiangiogenic activity of 2-deoxy-D-glucose. PLoS One, 2010, 5(10): e13699.
13
Cheng G, Zielonka J, Dranka BP, et al. Mitochondria-targeted drugs synergize with 2-deoxyglucose to trigger breast cancer cell death. Cancer Res, 2012, 72(10): 2634-2644.
[1] 孔莹莹, 谢璐涛, 卢晓驰, 徐杰丰, 周光居, 张茂. 丁酸钠对猪心脏骤停复苏后心脑损伤的保护作用及机制研究[J]. 中华危重症医学杂志(电子版), 2023, 16(05): 355-362.
[2] 张晓燕, 肖东琼, 高沪, 陈琳, 唐发娟, 李熙鸿. 转录因子12过表达对脓毒症相关性脑病大鼠大脑皮质的保护作用及其机制[J]. 中华妇幼临床医学杂志(电子版), 2023, 19(05): 540-549.
[3] 张再博, 王冰雨, 焦志凯, 檀碧波. 胃癌术后下肢深静脉血栓危险因素的Meta分析[J]. 中华普通外科学文献(电子版), 2023, 17(06): 475-480.
[4] 刘硕儒, 王功炜, 张斌, 李书豪, 胡成. 新型溶瘤病毒M1激活内质网应激致前列腺癌细胞凋亡的机制[J]. 中华腔镜泌尿外科杂志(电子版), 2023, 17(04): 388-393.
[5] 王甜甜, 温媛, 李振, 叶美红, 郭影, 马双. 和厚朴酚调控Nrf2/ARE通路对胃癌细胞的顺铂化疗敏感性的影响[J]. 中华细胞与干细胞杂志(电子版), 2023, 13(04): 202-209.
[6] 于迪, 于海波, 吴焕成, 李玉明, 苏彬, 陈馨. 发状分裂相关增强子1差异表达对胆固醇刺激下血管内皮细胞的影响[J]. 中华脑科疾病与康复杂志(电子版), 2023, 13(05): 264-270.
[7] 韩晓娟, 徐佳倩, 朱玉兰, 王莹, 李源, 冯珺, 邵东. HHLA2过表达胃癌细胞株构建及细胞功能的初步研究[J]. 中华消化病与影像杂志(电子版), 2023, 13(06): 373-377.
[8] 钟广俊, 刘春华, 朱万森, 徐晓雷, 王兆军. MRI联合不同扫描序列在胃癌术前分期诊断及化疗效果和预后的评估[J]. 中华消化病与影像杂志(电子版), 2023, 13(06): 378-382.
[9] 孙秀艳, 徐庆蕾, 马鹏涛, 胡志元, 郭传真, 祝成红. 腹腔镜胃癌根治术中患者体温变化与压力性损伤及受压部位微环境的相关性分析[J]. 中华消化病与影像杂志(电子版), 2023, 13(06): 480-484.
[10] 杨镠, 秦岚群, 耿茜, 李栋庆, 戚春建, 蒋华. 可溶性免疫检查点对胃癌患者免疫治疗疗效和预后的预测价值[J]. 中华消化病与影像杂志(电子版), 2023, 13(05): 305-311.
[11] 徐洪宇, 何亚爽. 羟考酮与氢吗啡酮用于胃癌根治术后镇痛的疗效[J]. 中华消化病与影像杂志(电子版), 2023, 13(05): 312-316.
[12] 盛静, 梅勇, 夏佩, 王晓林. 乌苯美司联合伊立替康二线治疗晚期胃癌的临床研究[J]. 中华消化病与影像杂志(电子版), 2023, 13(05): 317-321.
[13] 董青, 丁飞, 郭浩, 李峰. Nesfatin-1/NUCB2在幽门螺杆菌感染相关早期胃癌患者中的表达及临床意义[J]. 中华临床医师杂志(电子版), 2023, 17(07): 783-789.
[14] 王佳凤, 郭锐, 陈倩倩, 李惠凯, 宁波, 袁新普, 朱华, 令狐恩强. 68Ga-NC-BCH联合PET-CT淋巴结免疫示踪对于胃癌患者术前及术后临床决策影响的初步探索研究[J]. 中华胃肠内镜电子杂志, 2023, 10(04): 253-257.
[15] 邱甜, 杨苗娟, 胡波, 郭毅, 何奕涛. 亚低温治疗脑梗死机制的研究进展[J]. 中华脑血管病杂志(电子版), 2023, 17(05): 518-521.
阅读次数
全文


摘要

版权所有 中华医学会 中华医学电子音像出版社有限责任公司  京ICP备14006079号-1  网络出版服务许可证：(署)网出证(京)字第075号